Pharmaceutical Filtration Market Size, Share and Trends 2024 to 2034

Pharmaceutical Filtration Market Size and Growth 2024 to 2034

The global pharmaceutical filtration market size accounted for USD 13.04 billion in 2024 and is predicted to reach around USD 20.38 billion by 2034, growing at a CAGR of 4.57% from 2024 to 2034.

Pharmaceutical Filtration Market Key Takeaways

• North America led the global market with the highest market share of 41% in 2023.
• By Product, the membrane filters segment has held the largest market share in 2023.
• By Technique, the microfiltration segment captured the biggest revenue share in 2023.
• By Application, the final product processing segment is estimated to hold the highest market share in 2023.
• By Scale of Operation, the manufacturing scale segment registered the maximum market share of 65% in 2023.

U.S. Pharmaceutical Filtration Market Size and Growth 2024 to 2034

The U.S. pharmaceutical filtration market size was estimated at USD 3.58 billion in 2023 and is predicted to be worth around USD 5.90 billion by 2034, at a CAGR of 5% from 2024 to 2034.

North America dominates the pharmaceutical filtration market with a revenue share of 41% in 2023. The pharmaceutical industry in North America operates under strict regulatory standards set by agencies such as the U.S. Food and Drug Administration (FDA) and Health Canada. These regulatory bodies require pharmaceutical companies to adhere to high-quality standards in the production of drugs and therapeutic products. Filtration is a critical process in ensuring the purity and safety of pharmaceutical products, making advanced filtration technologies essential for compliance.

North America has a sizable biopharmaceutical sector that focuses on the production of biologics, including vaccines, antibodies, and other complex therapeutic proteins. The manufacturing processes for biopharmaceuticals often involve intricate filtration steps, driving the demand for specialized filtration technologies.

Pharmaceutical Filtration Market Growth Factors

The growth of global pharmaceutical filtration market is being driven by growing investments and funding in research and development activities. In addition, the growing acceptance of advanced treatment therapies and methods. Moreover, the rising number of market players are heavily investing in manufacturing facilities globally. For example, AbbVie Inc. funded roughly $320 million in a new small molecule and biologic active pharmaceutical ingredients manufacturing facility in Singapore in October 2016. As a result, demand for innovative products is expected to increase as biopharmaceutical firms expand.

Another factor driving the growth of global pharmaceutical filtration market is the adoption of innovative technologies by market players. In addition, the market players are investing in research and development initiatives for launching new and latest products in the global market. For example, in 2016, AstraZeneca, a renowned healthcare business, funded over $5,890 million on research and development. Furthermore, the market for pharmaceutical filtration is growing due to the rising prevalence of chronic disorders like asthma and cancer. The global pharmaceutical filtration market is also propelled by the development of advanced drugs and medications over the forecast period.

Pharmaceutical Filtration Market Scope

Product Insights

Themembrane filters segment dominated the pharmaceutical filtration market in 2023. This is owing to its versatility in applications such nanofiltration, ultrafiltration, cross-flow filtration, and microfiltration. As membrane filters are utilized in so many applications, the market share is predicted to grow significantly during the projection period.

The single use systems segment is fastest growing segment over the forecast period. These systems offer a number of benefits, including decreased contamination risk, reduced operation time, and ease of use. As a result, single use systems are projected to become more popular in upcoming years. They are also small in size, so they take up less room in factories.

Technique Insights

The microfiltration segment dominated the pharmaceutical filtration market in 2023. Microfiltration is a technology for clarifying, separating, and purifying proteins that is widely utilized. The feed stream flows parallel to the membrane in tangential flow microfiltration, which prevents plant pollutants from clogging the membrane. The lateral flow microfiltration can thus be utilized to simplify difficult to filter results like crude plant extracts, which induce membrane fouling quickly when filtered with traditional dead-end procedures.

The ultrafiltration segment is expected to witness significant growth over the forecast period. Due to its various applications in protein purification, antibody processing, and vaccines, the ultrafiltration category is expected to increase at a profitable rate. The market players are laser focused on meeting the precise requirements of healthcare filtration processes. Merck Millipore, for example, introduced the Mobius FlexReady Solution in January 2013, which is a fully automated, ready-to-use solution that is perfect for contract manufacturing organizations with quickly changing demands.

Application Insights

The final product processing segment dominated the pharmaceutical filtration market in 2023. Due to its widespread use in active pharmaceutical component processing, vaccine processing, protein purification, virus clearance, and antibody processing, the final product processing segment is growing at a rapid pace over the forecast period.

The cell separation segment is projected to hit significant growth from 2024 to 2033. The synthesis of monoclonal antibodies, therapeutic proteins, and vaccines all need cell separation. For cell separation applications, depth filtration and microfiltration are widely utilized. These items are expected to be widely used in emerging and established nations. The leading healthcare firms, well developed healthcare infrastructure, and modern goods all support the growth of the segment.

Scale of Operation Insights

The manufacturing scale segment dominated the pharmaceutical filtration market in 2023. Due to increased production of generic medications, biopharmaceuticals, and vaccines utilized for treatment of numerous disorders, the manufacturing scale of operation retained the biggest market share.

The research and development scale segment is predicted to hit notable growth over the forecast period. Due to increased funding and investment in research and development for new technology and product development, the research and development scale segment is expected to grow at a significant rate throughout the forecast period. For example, member organizations of the Pharmaceutical Research and Manufacturers of America spent roughly $58.8 billion on research and development in 2015.

Pharmaceutical Filtration Market Companies

• Graver Technologies, LLC
• Meissner Filtration Products, Inc.
• Merck & Co., Inc.
• Parker-Hannifin Corporation
• Sartorius Stedim Biotech S.A.
• 3M Company
• Amazon Filters Ltd.
• Danaher Corporation (Pall Corporation)
• Eaton Corporation Plc
• General Electric Company (GE Healthcare)

Recent Developments

• Danaher Corporation acquired Pall Corporation in August 2015 and joined the separation, filtration, and purification solutions market. 
• Sartorius AG purchased Watersep in December 2020, a company that makes hollow fiber membrane devices and pre-sterilized assemblies for biopharmaceutical applications downstream and upstream. Sartorius’s process filtration offering will be strengthened as a result of this acquisition. 
• Parker Hannifin Corporation, a global pioneer in motion and control technology, launched Protura SB Nano Pleated Filters in February 2020.
• Amazon Web Services and GE Healthcare will collaborate in August 2021 to provide healthcare providers and hospitals with artificial intelligence and cloud-based imaging solutions. 

 Segments Covered in the Report

By Product

• Membrane Filters
• MCE membrane filters
• Coated cellulose acetate membrane filters
• PTFE membrane filters
• Nylon membrane filters
• PVDF membrane filters
• Other membrane filters
• Pre-filters & Depth Media
• Glass fiber filters
• PTFE fiber filters
• Single-use Systems
• Cartridges & Capsules 
• Filter Holders 
• Filtration Accessories 
• Filtration Assemblies
• Others

By Technique

• Microfiltration
• Ultrafiltration
• Crossflow filtration 
• Nanofiltration
• Others

By Application

• Final Product Processing
• Active pharmaceutical ingredient filtration
• Sterile filtration
• Protein purification
• Vaccines and antibody processing
• Formulation and filling solutions
• Viral clearance
• Raw Material Filtration
• Media buffer
• Pre-filtration
• Bioburden testing
• Cell Separation
• Water Purification
• Air Purification

By Scale of Operation

• Manufacturing scale
• Pilot-scale
• Research & development scale

By Systems

• Single Use
• Reusable

By Type

• Sterile Filtration
• Non-Sterile Filtration 

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa